7 employees
A biotech comany advancing tissue-selective drug delivery platform technologies to revolutionize drug development.
2019
$10M
from 2 investors over 2 rounds
N1 Life raised $10M on April 17, 2023
Investors: Legend Capital and FreeS Fund 峰瑞资本